Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I);Revisión de las novedades presentadas en el XXVII Congreso del Comité Europeo para el Tratamiento e Investigación en Esclerosis Múltiple (ECTRIMS) (I)

Revista de Neurologia

Volumn 54, Issue 11, 2012, Pages 677-691

  Fernández, Óscar ^a   Álvarez Cermeño, José C ^b   Arroyo González, Rafael ^c   Brieva, Lluís ^d   Carmen Calles Hernandez M ^e   Casanova Estruch, Bonaventura ^f   Comabella, Manuel ^g   de las Heras, Virginia ^c   García Merino, Juan A ^h   Hernández Pérez, Miguel A ⁱ   Izquierdo, Guillermo ^j   Meca Lallana, José E ^k   Muñoz García, Delicias ^l   Olascoaga, Javier ^m   Oreja Guevara, Celia ⁿ   Prieto, José M ^o   Ramió Torrentà, Lluís ^p   Rodríguez Antigüedad, Alfredo ^q   Romero Pinel, Lucía ^r   Sánchez, Fernando ^s   Téllez, Nieves ^t   Tintoré, Mar ^g   Montalban, Xavier ^g   more..

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HOSPITAL ARNAU DE VILANOVA   (Spain)

^e HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

ⁱ HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^j HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^k HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^l HOSPITAL XERAL CÍES   (Spain)

^m HOSPITAL DONOSTIA   (Spain)

ⁿ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^o HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^p HOSPITAL JOSEP TRUETA   (Spain)

^q HOSPITAL DE BASURTO   (Spain)

^r HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^s HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^t HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

more..

Author keywords

Diagnosis; ECTRIMS; Epidemiology; Multiple sclerosis

Indexed keywords

CEREBROSPINAL VENOUS INSUFFICIENCY; COMORBIDITY; DISEASE SEVERITY; EARLY DIAGNOSIS; GRAY MATTER; HUMAN; MEDICAL RESEARCH; MEDICAL SOCIETY; MICROFLORA; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROIMAGING; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITION; OPTICAL COHERENCE TOMOGRAPHY; REVIEW; VEIN INSUFFICIENCY;

EID: 84861993386     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5411.2012204     Document Type: Review

References (89)

1. Ochoa-Reparaz J, Mielcarz DW, Begum-Haque S, Kasper LH. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Ann Neurol 2011; 69: 240-7.
2. Riccio P. The molecular basis of nutritional intervention in multiple sclerosis: a narrative review. Complement Ther Med 2011; 19: 228-37.
3. Marrie RA, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D, et al. Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis. Neurology 2010; 74: 1041-7.
4. Munger K. Enviromental risk factors as triggers and co-factors for MS. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
5. Levin LI, Munger KL, O'Reilly EJ, Falk KI, Ascherio A. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 2010; 67: 824-30.
6. Handel AE, Williamson AJ, Disanto G, Handunnetthi L, Giovannoni G, Ramagopalan SV. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One 2010; 5: e12496.
7. Munger KL, Levin LI, O'Reilly EJ, Falk KI, Ascherio A. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler 2011; 17: 1185-93.
8. Lucas RM, Ponsonby AL, Dear K, Valery PC, Pender MP, Taylor BV, et al. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011; 76: 540-8.
9. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-8.
10. Willer CJ, Dyment DA, Sadovnick AD, Rothwell PM, Murray TJ, Ebers GC. Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005; 330: 120.
11. Munger KL, Zhang SM, O'Reilly E, Hernan MA, Olek MJ, Willett WC, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62: 60-5.
12. Lucas RM, Ponsonby AL, Dear K, Valery P, Pender MP, Burrows JM, et al. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination. Neurology 2011; 77: 371-9.
13. Cantorna MT, Hayes CE, DeLuca HF. 1,25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 1996; 93: 7861-4.
14. Spach KM, Hayes CE. Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 2005; 175: 4119-26.
15. Mowry E, Waubant E, McCulloch C, Okuda D, Evangelista A, Lincoln R, et al. Higher vitamin D levels are associated with the development of fewer T2-and gadolinium-enhancing brain MRI lesions in multiple sclerosis. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
16. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 2007; 61: 504-13.
17. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007; 61: 288-99.
18. Jafari N, Hintzen RQ. The association between cigarette smoking and multiple sclerosis. J Neurol Sci 2011; 311: 78-85.
19. Hedstrom AK, Baarnhielm M, Olsson T, Alfredsson L. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 2009; 73: 696-701.
20. Fusby JS, Kassmeier MD, Palmer VL, Perry GA, Anderson DK, Hackfort BT, et al. Cigarette smoke-induced effects on bone marrow B-cell subsets and CD4+:CD8+ T-cell ratios are reversed by smoking cessation: influence of bone mass on immune cell response to and recovery from smoke exposure. Inhal Toxicol 2010; 22: 785-96.
21. Motz GT, Eppert BL, Wortham BW, Amos-Kroohs RM, Flury JL, Wesselkamper SC, et al. Chronic cigarette smoke exposure primes NK cell activation in a mouse model of chronic obstructive pulmonary disease. J Immunol 2010; 184: 4460-9.
22. Riise T, Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, et al. Negative interaction between smoking and infectious mononucleosis in the risk of MS. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
23. Portaccio E, Ghezzi A, Hakiki B, Giannini M, Pastú L, Razzolini L, et al. Post-partum relapses and disability progression in patients with multiple sclerosis. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
24. Portaccio E, Ghezzi A, Hakiki B, Martinelli V, Moiola L, Patti F, et al. Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology 2011; 77: 145-50.
25. Ascherio A. Interactions in epidemiology. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
26. De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 2008; 70: 1113-8.
27. Ebers G. Vitamin D and MS risk. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
28. Orton SM, Wald L, Confavreux C, Vukusic S, Krohn JP, Ramagopalan SV, et al. Association of UV radiation with multiple sclerosis prevalence and sex ratio in France. Neurology 2011; 76: 425-31.
29. Lucas R. Gene-environment interactions in the Ausimmune study. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
30. Taylor BV, Lucas RM, Dear K, Kilpatrick TJ, Pender MP, Van der Mei IA, et al. Latitudinal variation in incidence and type of first central nervous system demyelinating events. Mult Scler 2010; 16: 398-405.
31. Ramagopalan SV, Link J, Byrnes JK, Dyment DA, Giovannoni G, Hintzen RQ, et al. HLA-DRB1 and month of birth in multiple sclerosis. Neurology 2009; 73: 2107-11.
32. Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA, et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009; 5: e1000369.
33. Giovannoni G. Epstein-Barr virus and MS. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
34. Ramagopalan SV, Meier UC, Conacher M, Ebers GC, Giovannoni G, Crawford DH, et al. Role of the HLA system in the association between multiple sclerosis and infectious mononucleosis. Arch Neurol 2011; 68: 469-72.
35. Sundqvist E, Sundstrom P, Linden M, Hedstrom AK, Aloisi F, Hillert J, et al. Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun 2012; 13: 14-20.
36. Gasca-Salas C, Gómez-Ibáñez A. Insuficiencia venosa cerebroespinal crónica y esclerosis múltiple: revisión y actualización del tema. Rev Neurol 2011; 53: 555-60.
37. Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Tacconi G, Dall'Ara S, et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2009; 80: 392-9.
38. Doepp F. Review of current data related to CCSVI and MS. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
39. Miller A. New media and communications with patients: CCSVI as a case-study. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
40. Doepp F, Paul F, Valdueza JM, Schmierer K, Schreiber SJ. No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol 2010; 68: 173-83.
41. Doepp F, Wurfel JT, Pfueller CF, Valdueza JM, Petersen D, Paul F, et al. Venous drainage in multiple sclerosis: a combined MRI and ultrasound study. Neurology 2011; 77: 1745-51.
42. Centonze D, Floris R, Stefanini M, Rossi S, Fabiano S, Castelli M, et al. Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity. Ann Neurol 2011; 70: 51-8.
43. Baracchini C, Perini P, Calabrese M, Causin F, Rinaldi F, Gallo P. No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset. Ann Neurol 2011; 69: 90-9.
44. Baracchini C, Perini P, Causin F, Calabrese M, Rinaldi F, Gallo P. Progressive multiple sclerosis is not associated with chronic cerebrospinal venous insufficiency. Neurology 2011; 77: 844-50.
45. Zivadinov R, López-Soriano A, Weinstock-Guttman B, Schirda CV, Magnano CR, Dolic K, et al. Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects. Radiology 2011; 258: 562-70.
46. Laupacis A, Lillie E, Dueck A, Straus S, Perrier L, Burton JM, et al. Association between chronic cerebrospinal venous insufficiency and multiple sclerosis: a meta-analysis. CMAJ 2011; 183: e1203-12.
47. Diaconu C, Staugaitis S, McBride D, Schwanger C, Rae-Grant A, Fox R. Anatomical and histological analysis of venous structures associated with chronic cerebro-spinal venous insufficiency. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
48. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria Ann Neurol 2011; 69: 292-302.
49. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-7.
50. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol 2005; 58: 840-6.
51. Vukusic S. Shifting phenotype and 'NMO-spectrum disorders'. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
52. Mueller-Lenke N, Kappos L, Pehrs-Juvillier A, Naegelin Y, Bendfeldt K, Sprenger T, et al. Developmental venous anomaly as differential diagnosis of acute multiple sclerosis plaques: findings in a cohort of 3,643 patients. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
53. Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Morris PG, et al. 3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions. J Magn Reson Imaging 2010; 32: 971-7.
54. Mainero C, Benner T, Radding A, Van der Kouwe A, Jensen R, Rosen BR, et al. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology 2009; 73: 941-8.
55. Kollia K, Maderwald S, Putzki N, Schlamann M, Theysohn JM, Kraff O, et al. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5 T and 7 T. AJNR Am J Neuroradiol 2009; 30: 699-702.
56. Filippi M, Rocca MA, Calabrese M, Sormani MP, Rinaldi F, Perini P, et al. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology 2010; 75: 1988-94.
57. Seewann A, Vrenken H, Kooi EJ, van der Valk P, Knol DL, Polman CH, et al. Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis. Mult Scler 2011; 17: 1202-10.
58. Schmierer K, Parkes HG, So PW, An SF, Brandner S, Ordidge RJ, et al. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. Brain 2010; 133: 858-67.
59. Gaitán MI, Shea CD, Evangelou IE, Stone RD, Fenton KM, Bielekova B, et al. Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions. Ann Neurol 2011; 70: 22-9.
60. Balcer L. OCT in optic neuritis and MS subtypes. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
61. Costello F, Hodge W, Pan YI, Freedman M, DeMeulemeester C. Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes. J Neurol Sci 2009; 281: 74-9.
62. Henderson AP, Altmann DR, Trip AS, Kallis C, Jones SJ, Schlottmann PG, et al. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials. Brain 2010; 133: 2592-602.
63. Talman LS, Bisker ER, Sackel DJ, Long DA Jr, Galetta KM, Ratchford JN, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 2010; 67: 749-60.
64. Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, Ford E, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain 2012; 135: 521-33.
65. Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, Meyer SA, et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler 2011; 17: 1449-63.
66. Oberwahrenbrock T, Ringelstein M, Young K, Kaufhold F, Zimmermann H, Keser N, et al. Pattern of retinal alteration in different types of multiple sclerosis measured by highresolution optical coherence tomography. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
67. Ratchford J, Seigo M, Farrell S, Shiee N, Eckstein C, Saidha S, et al. Retinal nerve fibre layer thickness is associated with rate of brain atrophy. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
68. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodríguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707-17.
69. Aloisi F. CNS B-cells: do they matter? 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
70. Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, Gentleman SM, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 2011; 134: 2755-71.
71. Molnarfi N, Patarroyo J, Prod'homme T, Weber M, Linington C, Slavin A, et al. Myelin-specific B cell receptor transgenic mice reveal critical role for B cell accessory function independent of antibodies in pathogenesis of CNS autoimmune disease. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
72. Bar-Or A. Effects of peripheral B-cell depletion. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
73. Kappos L, Hartung HP, Freedman MS, Boyko A, Mikol D, Freudensprung U, et al. ATAMS: a randomised trial of the B-cell-targeting agent atacicept in patients with relapsing multiple sclerosis. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
74. Stadelmann C. Pathological substrates of MS neurodegeneration. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
75. Scalfari A, Neuhaus A, Degenhardt A, Rice GP, Muraro PA, Daumer M, et al. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. Brain 2010; 133: 1914-29.
76. DeLuca GC, Williams K, Evangelou N, Ebers GC, Esiri MM. The contribution of demyelination to axonal loss in multiple sclerosis. Brain 2006; 129: 1507-16.
77. Schirmer L, Albert M, Buss A, Schulz-Schaeffer WJ, Antel JP, Bruck W, et al. Substantial early, but nonprogressive neuronal loss in multiple sclerosis spinal cord. Ann Neurol 2009; 66: 698-704.
78. Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, Serafini B, et al. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010; 68: 477-93.
79. Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009; 132: 1175-89.
80. Perry H. Contribution of systemic inflammation to MS neurodegeneration. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
81. Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology 2009; 73: 768-74.
82. Moreno B, Jukes JP, Vergara-Irigaray N, Errea O, Villoslada P, Perry VH, et al. Systemic inflammation induces axon injury during brain inflammation. Ann Neurol 2011; 70: 932-42.
83. Tiwari-Woodruff S, Patel R, Moore S, Sasidhar M. Laquinimod treatment enhances myelination and prevents neurodegeneration in the chronic EAE mouse model of MS 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
84. Fisher E, Lee JC, Nakamura K, Rudick RA. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008; 64: 255-65.
85. Geurts JJC. Visualization and mechanisms of grey matter damage. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
86. Geurts JJ, Roosendaal SD, Calabrese M, Ciccarelli O, Agosta F, Chard DT, et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 2011; 76: 418-24.
87. Calabrese M, Rinaldi F, Seppi D, Favaretto A, Mattisi I, Perini P, et al. Fractional anisotropy is increased in the normal appearing cortical grey matter in multiple sclerosis. A threeyear longitudinal study. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
88. Gray E, Ginty M, Hares K, Love S, Scolding N, Wilkins A. Changes in peroxisomal function in cerebral cortex in multiple sclerosis are linked to neurodegeneration. 5th Joint Triennial ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.
89. Riccitelli G, Rocca MA, Pagani E, Martinelli V, Radaelli M, Falini A, et al. Regional grey matter atrophy is largely unrelated to white-matter tissue loss in relapsing-remitting multiple sclerosis. 5th Joint Triennial Congress of ECTRIMS and ACTRIMS. Amsterdam, NL, October 2011.